• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

The Weekly Roundup: December 26-30


ICYMI, this week we had stories about the top 5 articles of 2022, adjuvant treatment for Merkel cell carcinoma, favorite skin care products of 2022, and more.

Pulsed Dye Lasers for Cosmetic Procedures

Pulsed dye lasers are now being used for several different dermatologic conditions.

Top 5 Articles of 2022

As 2022 comes to a close, take a look at the top 5 articles from the year.

POLL: What Content Do You Want to See More of in 2023?

Click here to answer this week's poll.

2022 Top Trends and What’s Next in Dermatology

Dermatology Times®’ Editorial Board offers insight on what they loved about 2022, and what they hope to see in 2023.

Adjuvant Treatment for Merkel Cell Carcinoma

Merkel cell carcinoma is a rare, aggressive cutaneous malignancy that originates due to the uncontrollable proliferation of Merkel cells.

Q&A: Muneeb Shah, DO, Discusses What it Means to Have Healthy Skin

Dermatology Times® spoke with Shah in November on how he uses his social media platform to fight healthy skin misinformation.

2022 in Review: Benzene Contamination

A look back at benzene found in personal care products throughout the year and how companies have responded.

Cost-Effectiveness of Treating Advanced Melanoma

To date, it is unknown what impact potential response-adapted treatment strategies for advanced melanoma may have economically.

What’s Trending in Skin Care: December 2022

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are trending for the month of December.

Plaque Psoriasis Treatment: Roflumilast Adverse Effects

Linda Stein Gold, MD, and Jennifer Soung, MD, provide an overview of the safety profile and topical vehicle of roflumilast for the treatment of plaque psoriasis.

Tapinarof: Plaque Psoriasis Phase III Trial Overview

Linda Stein Gold, MD, reviews phase III data for the topical agent tapinarof for the treatment of plaque psoriasis.

Trending Skin Care Products of 2022

Dermatology Times® features a roundup of trending skin care products each month. Find out what products we enjoyed the most from 2022.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.